A new stem cell-based treatment may help patients with late-stage metastatic cancer live longer, according to researchers at the University of Michigan. The treatment includes the introduction of stem cells to the stomach, providing a layer of protection against harsh chemoradiotherapy.
The treatment technique was tested in mice and 50 to 75 percent survived the harsh cancer treatment. There were no survivors in a test group that did not receive the treatment.
"All tumors from different tissues and organs can be killed by high doses of chemotherapy and radiation, but the current challenge for treating the later-staged metastasized cancer is that you actually kill the patient before you kill the tumor," said lead researcher Jian-Guo Geng.
"Now we have found a way to protect the intestine. The next step is to aim for a 100-percent survival rate in mice who are injected with the molecules and receive lethal doses of chemotherapy and radiation."
For comments and feedback contact: editorial@rttnews.com
Health News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.